Raul Hernandes Bortolin, Ph.D., Pharm.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperlipoproteinemia Type II | 8 | 2024 | 396 | 1.160 |
Why?
|
| Diabetes Mellitus, Experimental | 7 | 2021 | 1121 | 1.020 |
Why?
|
| Calmodulin | 1 | 2024 | 239 | 0.870 |
Why?
|
| Osteoprotegerin | 3 | 2017 | 179 | 0.760 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2024 | 462 | 0.760 |
Why?
|
| Osteocalcin | 2 | 2016 | 271 | 0.630 |
Why?
|
| Myocytes, Cardiac | 2 | 2024 | 1673 | 0.620 |
Why?
|
| Diabetes Mellitus, Type 1 | 9 | 2022 | 3446 | 0.580 |
Why?
|
| Zinc | 2 | 2017 | 675 | 0.460 |
Why?
|
| MicroRNAs | 8 | 2023 | 3792 | 0.450 |
Why?
|
| Anabolic Agents | 1 | 2016 | 256 | 0.450 |
Why?
|
| RNA, Messenger | 10 | 2022 | 12791 | 0.450 |
Why?
|
| Brazil | 12 | 2023 | 1249 | 0.390 |
Why?
|
| Rats, Wistar | 9 | 2019 | 1889 | 0.390 |
Why?
|
| Bone Resorption | 1 | 2015 | 721 | 0.370 |
Why?
|
| Bone Density | 4 | 2017 | 3491 | 0.360 |
Why?
|
| Tamarindus | 2 | 2019 | 2 | 0.330 |
Why?
|
| Dietary Supplements | 3 | 2020 | 3429 | 0.320 |
Why?
|
| Matrix Metalloproteinase 9 | 3 | 2018 | 633 | 0.240 |
Why?
|
| RANK Ligand | 2 | 2017 | 321 | 0.240 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2024 | 3250 | 0.220 |
Why?
|
| Lipoprotein Lipase | 1 | 2024 | 133 | 0.220 |
Why?
|
| Cleft Lip | 2 | 2019 | 512 | 0.210 |
Why?
|
| Gene Expression Regulation | 7 | 2021 | 11920 | 0.210 |
Why?
|
| Bioreactors | 1 | 2024 | 244 | 0.210 |
Why?
|
| Cleft Palate | 2 | 2019 | 596 | 0.210 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2024 | 1882 | 0.200 |
Why?
|
| Passiflora | 1 | 2021 | 4 | 0.200 |
Why?
|
| Insulin | 1 | 2016 | 6608 | 0.200 |
Why?
|
| Ticlopidine | 2 | 2017 | 730 | 0.190 |
Why?
|
| Rats | 11 | 2021 | 23717 | 0.190 |
Why?
|
| Butyrylcholinesterase | 1 | 2020 | 21 | 0.180 |
Why?
|
| Polymorphism, Genetic | 4 | 2019 | 4249 | 0.180 |
Why?
|
| Asymptomatic Infections | 1 | 2021 | 136 | 0.180 |
Why?
|
| Cardiac Myosins | 1 | 2021 | 128 | 0.170 |
Why?
|
| Receptors, LDL | 4 | 2023 | 492 | 0.170 |
Why?
|
| Histocompatibility Antigens | 1 | 2021 | 479 | 0.170 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2020 | 106 | 0.170 |
Why?
|
| Tibia | 2 | 2016 | 1071 | 0.170 |
Why?
|
| Long QT Syndrome | 1 | 2024 | 473 | 0.170 |
Why?
|
| Cactaceae | 1 | 2019 | 1 | 0.160 |
Why?
|
| Femur | 2 | 2016 | 1318 | 0.160 |
Why?
|
| Receptors, Cholecystokinin | 1 | 2018 | 18 | 0.160 |
Why?
|
| Myosin Heavy Chains | 1 | 2021 | 403 | 0.160 |
Why?
|
| Glycemic Index | 2 | 2018 | 400 | 0.160 |
Why?
|
| Streptozocin | 2 | 2019 | 189 | 0.160 |
Why?
|
| Pregnant Women | 1 | 2024 | 576 | 0.160 |
Why?
|
| Plant Extracts | 2 | 2021 | 496 | 0.160 |
Why?
|
| Major Histocompatibility Complex | 1 | 2021 | 880 | 0.150 |
Why?
|
| Twins, Monozygotic | 1 | 2020 | 471 | 0.150 |
Why?
|
| Appetite Depressants | 1 | 2018 | 108 | 0.150 |
Why?
|
| Organoids | 1 | 2024 | 740 | 0.150 |
Why?
|
| Receptors, Calcitriol | 1 | 2020 | 361 | 0.150 |
Why?
|
| Sucrose | 1 | 2018 | 155 | 0.150 |
Why?
|
| Interferon Regulatory Factors | 1 | 2019 | 272 | 0.140 |
Why?
|
| Cocaine-Related Disorders | 1 | 2020 | 458 | 0.140 |
Why?
|
| Cell Culture Techniques | 1 | 2024 | 1646 | 0.140 |
Why?
|
| Action Potentials | 1 | 2024 | 1835 | 0.140 |
Why?
|
| Tacrolimus | 1 | 2020 | 753 | 0.140 |
Why?
|
| Up-Regulation | 4 | 2021 | 4142 | 0.130 |
Why?
|
| Plant Proteins | 1 | 2019 | 375 | 0.130 |
Why?
|
| INDEL Mutation | 1 | 2017 | 266 | 0.130 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2017 | 105 | 0.130 |
Why?
|
| Oleic Acid | 1 | 2016 | 89 | 0.130 |
Why?
|
| Achilles Tendon | 1 | 2019 | 181 | 0.130 |
Why?
|
| Eating | 2 | 2023 | 1539 | 0.130 |
Why?
|
| Receptors, Somatomedin | 1 | 2016 | 57 | 0.130 |
Why?
|
| Jejunum | 1 | 2018 | 474 | 0.130 |
Why?
|
| Exosomes | 1 | 2020 | 417 | 0.130 |
Why?
|
| PPAR gamma | 1 | 2019 | 484 | 0.130 |
Why?
|
| E-Selectin | 1 | 2018 | 575 | 0.130 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2017 | 91 | 0.130 |
Why?
|
| Troponin T | 1 | 2021 | 786 | 0.130 |
Why?
|
| Collagen Type I | 2 | 2019 | 616 | 0.130 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2018 | 692 | 0.130 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2016 | 190 | 0.120 |
Why?
|
| Databases, Nucleic Acid | 1 | 2016 | 203 | 0.120 |
Why?
|
| Tendon Injuries | 1 | 2019 | 329 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2021 | 18075 | 0.120 |
Why?
|
| Carcinoma, Papillary | 1 | 2020 | 791 | 0.120 |
Why?
|
| Cerebellar Neoplasms | 1 | 2020 | 588 | 0.120 |
Why?
|
| Diabetic Nephropathies | 1 | 2022 | 975 | 0.120 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2018 | 407 | 0.120 |
Why?
|
| Albuminuria | 1 | 2018 | 659 | 0.120 |
Why?
|
| Medulloblastoma | 1 | 2020 | 679 | 0.120 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2018 | 1131 | 0.120 |
Why?
|
| Elastic Modulus | 1 | 2015 | 209 | 0.110 |
Why?
|
| Violence | 1 | 2020 | 931 | 0.110 |
Why?
|
| Obesity | 4 | 2023 | 13090 | 0.110 |
Why?
|
| Physical Conditioning, Animal | 1 | 2017 | 366 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2022 | 1852 | 0.110 |
Why?
|
| Lipid Metabolism | 1 | 2021 | 1895 | 0.100 |
Why?
|
| Animals | 14 | 2024 | 168930 | 0.100 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2016 | 637 | 0.100 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2021 | 1336 | 0.090 |
Why?
|
| Dyslipidemias | 1 | 2019 | 872 | 0.090 |
Why?
|
| Adipocytes | 1 | 2018 | 1196 | 0.090 |
Why?
|
| Metformin | 1 | 2018 | 908 | 0.090 |
Why?
|
| Body Composition | 1 | 2020 | 2441 | 0.090 |
Why?
|
| Leptin | 1 | 2018 | 1596 | 0.090 |
Why?
|
| Genotype | 6 | 2021 | 13036 | 0.090 |
Why?
|
| 3' Untranslated Regions | 2 | 2023 | 515 | 0.090 |
Why?
|
| Hep G2 Cells | 2 | 2021 | 378 | 0.090 |
Why?
|
| Male | 25 | 2024 | 364142 | 0.080 |
Why?
|
| Cholesterol, LDL | 3 | 2024 | 2392 | 0.080 |
Why?
|
| Hypoglycemic Agents | 2 | 2021 | 3108 | 0.080 |
Why?
|
| Proteome | 1 | 2020 | 1894 | 0.080 |
Why?
|
| Ventricular Remodeling | 1 | 2017 | 1281 | 0.080 |
Why?
|
| Humans | 34 | 2024 | 766766 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2024 | 11651 | 0.080 |
Why?
|
| Blood Glucose | 6 | 2019 | 6422 | 0.080 |
Why?
|
| Mice, Knockout | 1 | 2024 | 14471 | 0.080 |
Why?
|
| Cytokines | 2 | 2020 | 7438 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2016 | 1935 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2024 | 16044 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2020 | 4215 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2021 | 4924 | 0.070 |
Why?
|
| Down-Regulation | 3 | 2021 | 2931 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 18330 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 3041 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2021 | 3989 | 0.070 |
Why?
|
| Nanoparticles | 1 | 2018 | 1966 | 0.070 |
Why?
|
| Peptides | 1 | 2019 | 4344 | 0.070 |
Why?
|
| Vitamin D | 1 | 2020 | 3270 | 0.070 |
Why?
|
| Diet | 1 | 2024 | 8088 | 0.060 |
Why?
|
| Adult | 16 | 2024 | 223307 | 0.060 |
Why?
|
| Blood Platelets | 1 | 2016 | 2465 | 0.060 |
Why?
|
| Kidney Transplantation | 1 | 2020 | 4278 | 0.060 |
Why?
|
| Mutation | 4 | 2023 | 30213 | 0.060 |
Why?
|
| Aspirin | 1 | 2017 | 3135 | 0.060 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2017 | 2763 | 0.060 |
Why?
|
| Cardiomyopathies | 1 | 2017 | 2059 | 0.060 |
Why?
|
| Prognosis | 6 | 2021 | 29948 | 0.060 |
Why?
|
| Receptor, Melanocortin, Type 3 | 1 | 2023 | 12 | 0.060 |
Why?
|
| Inflammation | 2 | 2021 | 10860 | 0.060 |
Why?
|
| Mutation, Missense | 2 | 2022 | 2590 | 0.050 |
Why?
|
| Female | 19 | 2024 | 396520 | 0.050 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2023 | 131 | 0.050 |
Why?
|
| HLA-A Antigens | 1 | 2022 | 223 | 0.050 |
Why?
|
| Protein Stability | 1 | 2024 | 578 | 0.050 |
Why?
|
| Pectins | 1 | 2021 | 27 | 0.050 |
Why?
|
| Genes, MHC Class II | 1 | 2022 | 433 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2019 | 1197 | 0.050 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2023 | 558 | 0.050 |
Why?
|
| Carbohydrates | 1 | 2023 | 387 | 0.050 |
Why?
|
| Molecular Conformation | 1 | 2022 | 540 | 0.050 |
Why?
|
| Apolipoproteins B | 1 | 2022 | 385 | 0.050 |
Why?
|
| Forensic Genetics | 1 | 2020 | 10 | 0.050 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2020 | 117 | 0.040 |
Why?
|
| Resistin | 1 | 2021 | 174 | 0.040 |
Why?
|
| Genetic Association Studies | 2 | 2021 | 2746 | 0.040 |
Why?
|
| Interleukin-18 | 1 | 2022 | 251 | 0.040 |
Why?
|
| Middle Aged | 11 | 2024 | 223257 | 0.040 |
Why?
|
| Heart Septum | 1 | 2021 | 303 | 0.040 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2022 | 347 | 0.040 |
Why?
|
| Child | 7 | 2024 | 80668 | 0.040 |
Why?
|
| Liver | 3 | 2021 | 7571 | 0.040 |
Why?
|
| Mutagenicity Tests | 1 | 2019 | 46 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 12245 | 0.040 |
Why?
|
| Cryopreservation | 1 | 2024 | 727 | 0.040 |
Why?
|
| Meta-Analysis as Topic | 1 | 2024 | 1365 | 0.040 |
Why?
|
| Satiety Response | 1 | 2018 | 47 | 0.040 |
Why?
|
| Collagen Type III | 1 | 2019 | 92 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2023 | 8728 | 0.040 |
Why?
|
| Simvastatin | 1 | 2021 | 345 | 0.040 |
Why?
|
| Sunlight | 1 | 2020 | 336 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2017 | 5887 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 6558 | 0.040 |
Why?
|
| Seeds | 1 | 2018 | 125 | 0.040 |
Why?
|
| Plants, Medicinal | 1 | 2019 | 166 | 0.040 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2022 | 588 | 0.040 |
Why?
|
| Microscopy, Atomic Force | 1 | 2018 | 250 | 0.040 |
Why?
|
| Electrophoresis, Capillary | 1 | 2017 | 63 | 0.040 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2019 | 246 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 6962 | 0.040 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2022 | 582 | 0.040 |
Why?
|
| Mice | 1 | 2024 | 81889 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2019 | 4349 | 0.030 |
Why?
|
| Exons | 1 | 2023 | 2392 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 2021 | 988 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 2019 | 386 | 0.030 |
Why?
|
| Salicylic Acid | 1 | 2017 | 62 | 0.030 |
Why?
|
| Hair | 1 | 2020 | 508 | 0.030 |
Why?
|
| Aged | 8 | 2022 | 171343 | 0.030 |
Why?
|
| Carboxylic Acids | 1 | 2017 | 91 | 0.030 |
Why?
|
| Adolescent | 6 | 2022 | 88904 | 0.030 |
Why?
|
| Pharmacogenetics | 1 | 2020 | 682 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2018 | 456 | 0.030 |
Why?
|
| Consanguinity | 1 | 2018 | 460 | 0.030 |
Why?
|
| Fruit | 1 | 2021 | 1166 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2020 | 22248 | 0.030 |
Why?
|
| Phosphorus | 1 | 2017 | 336 | 0.030 |
Why?
|
| Gene Expression | 2 | 2018 | 7585 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2023 | 1806 | 0.030 |
Why?
|
| Cocaine | 1 | 2020 | 944 | 0.030 |
Why?
|
| Alveolar Bone Loss | 1 | 2018 | 394 | 0.030 |
Why?
|
| Periodontal Diseases | 1 | 2018 | 453 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2017 | 461 | 0.030 |
Why?
|
| Maternal Age | 1 | 2018 | 804 | 0.030 |
Why?
|
| Phenotype | 2 | 2023 | 16724 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 11061 | 0.030 |
Why?
|
| Epigenomics | 1 | 2020 | 959 | 0.030 |
Why?
|
| Ovariectomy | 1 | 2017 | 612 | 0.030 |
Why?
|
| Thyroidectomy | 1 | 2020 | 912 | 0.030 |
Why?
|
| Random Allocation | 1 | 2019 | 2394 | 0.030 |
Why?
|
| Cholesterol | 1 | 2023 | 2903 | 0.030 |
Why?
|
| Particle Size | 1 | 2018 | 1634 | 0.030 |
Why?
|
| Sex Factors | 2 | 2018 | 10619 | 0.030 |
Why?
|
| Heterozygote | 1 | 2021 | 2795 | 0.030 |
Why?
|
| Hypercholesterolemia | 1 | 2021 | 1145 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2017 | 855 | 0.030 |
Why?
|
| Anticholesteremic Agents | 1 | 2021 | 970 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 17088 | 0.030 |
Why?
|
| Young Adult | 4 | 2022 | 59939 | 0.030 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2016 | 385 | 0.030 |
Why?
|
| Triglycerides | 1 | 2021 | 2441 | 0.030 |
Why?
|
| Intra-Abdominal Fat | 1 | 2018 | 624 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2017 | 996 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2019 | 2234 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 2846 | 0.030 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2021 | 1567 | 0.030 |
Why?
|
| Ethanol | 1 | 2019 | 1326 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2016 | 1168 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2021 | 4276 | 0.020 |
Why?
|
| Pancreas | 1 | 2018 | 1698 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2018 | 3624 | 0.020 |
Why?
|
| Maternal Exposure | 1 | 2018 | 1097 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 15657 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 59550 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 15908 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 4780 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 2232 | 0.020 |
Why?
|
| Incidence | 2 | 2018 | 21525 | 0.020 |
Why?
|
| Pregnancy | 2 | 2024 | 30237 | 0.020 |
Why?
|
| Alleles | 1 | 2020 | 6895 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2018 | 1851 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2021 | 3853 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2024 | 18984 | 0.020 |
Why?
|
| Linear Models | 1 | 2018 | 5874 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2019 | 4166 | 0.020 |
Why?
|
| Echocardiography | 1 | 2021 | 5037 | 0.020 |
Why?
|
| Body Weight | 1 | 2019 | 4626 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3796 | 0.020 |
Why?
|
| Lipids | 1 | 2019 | 3319 | 0.020 |
Why?
|
| Wound Healing | 1 | 2019 | 2800 | 0.020 |
Why?
|
| Risk Factors | 3 | 2021 | 74881 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2022 | 42577 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39309 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 6307 | 0.020 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 1535 | 0.020 |
Why?
|
| Skin | 1 | 2020 | 4499 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2017 | 2559 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 20144 | 0.020 |
Why?
|
| Proteomics | 1 | 2020 | 3914 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2021 | 6612 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 10264 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 10745 | 0.010 |
Why?
|
| Genomics | 1 | 2020 | 5923 | 0.010 |
Why?
|
| Acute Coronary Syndrome | 1 | 2017 | 2186 | 0.010 |
Why?
|
| Calcium | 1 | 2017 | 5783 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2020 | 65273 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2024 | 26389 | 0.010 |
Why?
|
| Myocardium | 1 | 2016 | 4765 | 0.010 |
Why?
|
| Comorbidity | 1 | 2018 | 10580 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2018 | 8066 | 0.010 |
Why?
|
| Age Factors | 1 | 2018 | 18397 | 0.010 |
Why?
|
| Smoking | 1 | 2018 | 9077 | 0.010 |
Why?
|
| Prevalence | 1 | 2018 | 15835 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2020 | 81635 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9525 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2024 | 54871 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2018 | 24295 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 36461 | 0.010 |
Why?
|